drugset / Trial / NCT02707107

MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers

NCT02707107

Phase 1 Completed 20 enrolled Wockhardt Quintiles, Inc. · collab
RandomizedParallel-groupQuadruple-blind

Summary

Study to evaluate the safety, tolerability and pharmacokinetics of multiple escalating doses of intravenous WCK 5222 (Zidebactam and Cefepime) in healthy adult human subjects.

Timeline

Start
2016-03
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefepime Small molecule 2 g Intravenous
Comparator Zidebactam Small molecule 1 g Intravenous